WeVote
Log In

Bill

DH

Bill

A 4814

Establishes tianeptine as Schedule II controlled dangerous substance.

2024-2025 Regular Session Introduced by Dan Hutchison and 2 co-sponsors

New Jersey reclassifies tianeptine as Schedule II controlled substance to regulate unregistered sales and address emerging public health risks from casual recreational use.

Received in the Senate without Reference, 2nd Reading
#drugabuse
0
WeVote Research Nonpartisan
Bill Summary · A 4814

Legislative bill overview

Bill A 4814 classifies tianeptine, a atypical antidepressant drug, as a Schedule II controlled dangerous substance in New Jersey. This designation would subject the drug to strict regulatory controls similar to those applied to prescription medications with abuse potential, including prescription requirements, pharmacy tracking, and criminal penalties for unauthorized possession or distribution.

Why is this important

Tianeptine has recently emerged as an unregulated substance marketed under names like "Za Za Red" and "Tianna" in gas stations and online retailers, often sold as a dietary supplement or nootropic despite its psychoactive effects. Classifying it as Schedule II aims to address growing concerns about public health risks, including dependency, overdose, and use particularly among younger populations who may not understand its dangers.

Potential points of contention

  • Medical use vs. scheduling: Tianeptine has legitimate psychiatric applications in some countries; strict Schedule II classification may limit research or clinical access for patients who could benefit therapeutically
  • Efficacy of scheduling: Critics question whether regulatory scheduling addresses the root problem of unregulated supplement markets and whether enforcement resources could be better deployed
  • Due process concerns: Rapid passage (75-0 in Assembly) without apparent public comment period or medical expert testimony may raise questions about the legislative process despite broad support

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.